Abstract
1 Residual effects in man of methaqualone hydrochloride (400 mg) were studied by adaptive tracking and by reaction time. Performance was measured at 10 h, 13 h, 16 h, 19 h and 34 h after the overnight ingestion of the drug. There was no evidence of impaired performance on adaptive tracking from 10 h to 19 h, but enhanced performance (P = 0.001) was observed 34 h after ingestion. With reaction time an increase (P = 0.01) was observed 10 h and a decrease (P = 0.05) was observed 19 h after ingestion. 2 Effects in the monkey (Macaca mulatta) of methaqualone (20 and 30 mg/kg body weight) were studied by a delayed matching task in which total response time was measured. No consistent effects on matching behaviour or on total response time were observed 2 h after intraperitoneal injection. 3 The studies suggest that methaqualone hydrochloride may be a valuable hypnotic for occasional use by persons involved in skilled activity.
Full text
PDF![131](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e3d/1402519/4e571cf9759e/brjclinpharm00277-0037.png)
![132](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e3d/1402519/189a3cdf22c6/brjclinpharm00277-0038.png)
![133](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e3d/1402519/40d601355464/brjclinpharm00277-0039.png)
![134](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e3d/1402519/866686c7d3d5/brjclinpharm00277-0040.png)
![135](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e3d/1402519/ff310a01297d/brjclinpharm00277-0041.png)
![136](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e3d/1402519/6a172f0adf0a/brjclinpharm00277-0042.png)
![137](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e3d/1402519/58d2cbb3837d/brjclinpharm00277-0043.png)
![138](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e3d/1402519/f460f2385724/brjclinpharm00277-0044.png)
![139](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e3d/1402519/f55b3bf6579e/brjclinpharm00277-0045.png)
![140](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e3d/1402519/34b96b62d5ae/brjclinpharm00277-0046.png)
![141](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e3d/1402519/74e11bc783aa/brjclinpharm00277-0047.png)
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Alván G., Lindgren J. E., Bogentoft C., Ericsson O. Plasma kinetics of methaqualone in man after single oral doses. Eur J Clin Pharmacol. 1973 Oct;6(3):187–190. doi: 10.1007/BF00558284. [DOI] [PubMed] [Google Scholar]
- Bond A. J., Lader M. H. Residual effects of hypnotics. Psychopharmacologia. 1972;25(2):117–132. doi: 10.1007/BF00423189. [DOI] [PubMed] [Google Scholar]
- Bond A. J., Lader M. H. The residual effects of flurazepam. Psychopharmacologia. 1973 Sep 28;32(3):223–235. doi: 10.1007/BF00422145. [DOI] [PubMed] [Google Scholar]
- Borland R. G., Nicholson A. N. Comparison of the residual effects of two benzodiazepines (nitrazepam and flurazepam hydrochloride) and pentobarbitone sodium on human performance. Br J Clin Pharmacol. 1975 Feb;2(1):9–17. doi: 10.1111/j.1365-2125.1975.tb00465.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Clifford J. M., Cookson J. H., Wickham P. E. Absorption and clearance of secobarbital, heptabarbital, methaqualone, and ethinamate. Clin Pharmacol Ther. 1974 Aug;16(2):376–389. doi: 10.1002/cpt1974162376. [DOI] [PubMed] [Google Scholar]
- FAZEKAS J. F., GOLDBAUM L. R., KOPPANYI T., SHEA J. G. Study of the effect of overdoses of pentylenetetrazol and barbiturate combinations in human volunteers. Am J Med Sci. 1956 May;231(5):531–541. doi: 10.1097/00000441-195605000-00006. [DOI] [PubMed] [Google Scholar]
- Glick S. D., Goldfarb T. L., Robustelli F., Geller A., Jarvik M. E. Impairment of delayed matching in monkeys by chlorpromazine and pentobarbital. Psychopharmacologia. 1969;15(2):125–133. doi: 10.1007/BF00407045. [DOI] [PubMed] [Google Scholar]
- HEBB D. O. Drives and the C.N.S. (conceptual nervous system). Psychol Rev. 1955 Jul;62(4):243–254. doi: 10.1037/h0041823. [DOI] [PubMed] [Google Scholar]
- KORNETSKY C., VATES T. S., KESSLER E. K. A comparison of hypnotic and residual psychological effects of single doses of chlorpromazine and secobarbital in man. J Pharmacol Exp Ther. 1959 Sep;127:51–54. [PubMed] [Google Scholar]
- Malpas A., Rowan A. J., Boyce C. R., Scott D. F. Persistent behavioural and electroencephalographic changes after single doses of nitrazepam and amylobarbitone sodium. Br Med J. 1970 Jun 27;2(5712):762–764. doi: 10.1136/bmj.2.5712.762. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nicholson A. N., Wright C. M., Ferres H. M. Impaired performance on delayed matching in monkeys by heptabarbitone, pentobarbitone sodium and quinalbarbitone sodium. Neuropharmacology. 1973 Apr;12(4):311–317. doi: 10.1016/0028-3908(73)90090-7. [DOI] [PubMed] [Google Scholar]
- Nicholson A. N., Wright C. M. Inhibitory and disinhibitory effects of nitrazepam, diazepam and flurazepam hydrochloride on delayed matching behaviour in monkeys (Macaca mulatta). Neuropharmacology. 1974 Nov;13(10-11):919–926. doi: 10.1016/0028-3908(74)90083-5. [DOI] [PubMed] [Google Scholar]
- Schwartz M. A., Postma E. Metabolism of flurazepam, a benzodiazepine, in man and dog. J Pharm Sci. 1970 Dec;59(12):1800–1806. doi: 10.1002/jps.2600591220. [DOI] [PubMed] [Google Scholar]
- VON FELSINGER J. M., LASAGNA L., BEECHER H. K. The persistence of mental impairment following a hypnotic dose of a barbiturate. J Pharmacol Exp Ther. 1953 Nov;109(3):284–291. [PubMed] [Google Scholar]